august 20, 2003 focus area 14: immunization and infectious diseases progress review
Post on 16-Jan-2016
218 Views
Preview:
TRANSCRIPT
August 20, 2003
Focus Area 14:Immunization and
Infectious Diseases Progress Review
Immunization and Infectious Disease Objectives
Immunization objectives
14-23 Vaccination in day care, grades K and 114-24 Fully immunized children
Plus others on
Disease prevalence Children and vaccinationProvider practice Immunization registriesHigh-risk adults Adverse eventsVaccine safety
Immunization and Infectious Disease ObjectivesInfectious Disease objectives
14-10 Identification of persons with chronic Hepatitis C.14-15 Prevention services for International travelers.
Plus others on
Hepatitis A, B, and C Bacterial meningitisPeptic ulcer hospitalizations Pneumococcal infections
Antibiotics use Meningococcal disease Hospital-acquired infections Lyme disease Anti-microbial use in ICU’s Group B streptococcal disease
.
Immunization and Infectious Disease Objectives
Tuberculosis objectives
TuberculosisCurative therapy for tuberculosis
Treatment for high-risk personsTimely laboratory confirmation
Morbidity Profile
Disease
Average prevalence
20th Cent. cases
2000 cases
Target
Measles 503,282 37 0
Diphtheria 175,885 1 0
Mumps 152,209 238 0
Pertussis 147,271 8,296 2,000
Rubella 47,745 14 0
H. Influenzae, type b 20,000 167 0
Polio (paralytic) 16,316 0 0
Tetanus 1,314 22 0
Congenital Rubella Syndrome 823 3 0
0
20
40
60
80
100
1967 1970 1973 1976 1979 1982 1985 1988 1991 1994 1997 2000
DTP(3+)
MMR(1+) Polio (3+)
Hib (3+)
Hep B (3+)
Varicella (1+)
Note: Children in the USIS and NHIS were 24-35 months of age. Children in the NIS were 19-35 months of age.Source: USIS (1967-1985), CDC, Division of Immunization, NHIS (1991-1993) CDC, NCHS, and NIS (1994-December 2002),
CDC, NIP and NCHS; No data from 1986-1990 due to cancellation of USIS because of budget reductions
2010 Target
Vaccine-specific coverage rates among pre-school aged children
Percent
405060708090
100
Hib (3+)
White, Not Hispanic
Black, Not Hispanic
Hispanic
American Indian / Alaskan Native
405060708090
100
Varicella (1+)
405060708090
100
MMR (1+)
405060708090
100
HepB (3+)
Asian
Universally Recommended Vaccination Coverage Among Children 19-35
Months, 2002
I 95% Confidence interval. § Data are statistically unreliable.Source: NIS, CDC, NIP and NCHS.
Percent Percent
Percent Percent
2010 Target
Native Hawaiian/ Other Pacific Islander Multiple Race
Obj. 14-22
§
§
§
White, Not Hispanic
Black, Not Hispanic
Hispanic
American Indian / Alaskan Native
405060708090
100
405060708090
100
405060708090
100
Asian
‡ Developmental objective. Target has not been determined.I 95% Confidence interval. § Data are statistically unreliable.Source: NIS, CDC, NIP and NCHS.
Universally Recommended Vaccination Coverage Among Children 19-35
Months, 2002
0
20
40
60
80
100
DTP (4+) DTP (3+)
Percent Percent
Percent
4:3:1:3:3 Series
2010 Target
PCV(3+)‡
Percent
Native Hawaiian/ Other Pacific Islander
Multiple Race
Obj. 14-22
§
§
§
§ § §
(2001)(2002)
0
10
20
30
40
50
60
70
80
90
Note: Percent receiving vaccine is estimated per Influenza season, using the January-June interviews only. Source: NHIS, CDC, NCHS.
2010 Target
Influenza Vaccination Coverage During the Past 12 Months, Among Adults 65
Years and Older
Percent
1988 1990 1992 1994 1996 1998 2000
Obj. 14-29a
2002
0102030405060708090
100
1998 1999 2000 2001 2002† Data are preliminary.
Source: NHIS, CDC, NCHS.
White
African American
Hispanic
2010 Target
Asian
Total
Pneumococcal Vaccination Coverage Ever Received Among Adults 65 Years
and OlderPercent
Obj. 14-29b
†
0
4
8
12
16
20
Hepatitis A Incidence
1999 ACIP recommendations
1996 ACIP recommendations
1995 vaccine licensure
† 2002 Data are preliminary.Source: NNDSS, CDC, EPO.
Cases per 100,000
1980 1985 1990 1995 2000
2010 Target
Obj. 14-6
2002
0
4
8
12
16
20
Hepatitis A Incidence
1999 ACIP recommendations
1996 ACIP recommendations
1995 vaccine licensure
† 2002 Data are preliminary.Source: NNDSS, CDC, EPO.
Cases per 100,000
1980 1985 1990 1995 2000
2010 Target
Obj. 14-6
2002
19 years and older
Less than 19 years old
Hepatitis B Incidence
0
5
10
15
20
25
30
35
40
45
50
Source: NNDSS, CDC, EPO.
Estimated cases per 100,000
19-39 years
40 years and older
Less than19 years
Obj. 14-3
1990 200220001998199619941992
1991 ACIP recommendations(for infant vaccination schedule)
Hepatitis B Incidence
1
10
100
Source: NNDSS, CDC, EPO.
Estimated cases per 100,000 (log-scale)
19-39 years
40 years and olderLess than19 years
Obj. 14-3
1990 200220001998199619941992
0
5
10
15
20
25
Hepatitis B Incidence, 2001
American Indian/ Alaska Native
I 95% Confidence interval.Source: NNDSS, CDC, EPO.
Per 100,000 2010 target
19-24 years 25-39 years 40 years and older
Asian or Pacific Islander
Hispanic
White, Not Hispanic
Black, Not Hispanic
Obj. 14-3
0
5
10
15
20
25
30
35
402010 target
Rates of Tuberculosis
Note: Data in parentheses represent the percent change in the rates between 1998 and 2001Source: NTBSS, CDC, NCHSTP.
20011998
American Indian or
Alaska Native
Asian or Pacific Islander
Black, Not Hispanic
White, Not Hispanic
HispanicTOTAL
Obj. 14-11
10000
14000
18000
22000
26000
83 85 87 89 91 93 95 97 99 2001
Per 100,000 population
(-15%)
(-11%)
(-12%)
(-13%)
(-20%)
(-26%)
0
20
40
60
80
100Percent 2010 target
Proportion of Tuberculosis Patients Completing Curative
Therapy
Source: NTBSS, CDC, NCHSTP.
19991996
American Indian or
Alaska Native
Asian or Pacific Islander
Black, Not Hispanic
White, Not Hispanic
HispanicTOTAL
Obj. 14-12
Progress Review data and slides can be found on the
web at:
http://www.cdc.gov/nchs/hphome.htm
top related